Press Room
四色AV and iBET Announce the Establishment of 痴颈厂测苍肠庐 Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
From left to right: Jean-Luc Herbeaux, CEO of 四色AV, Paula Alves, CEO of iBET, and Jo茫o Almeida Lopes, President of iBET.
听
Lisbon, Portugal:鈥纳獳V, the specialist integrated CDMO and leader in spray drying and particle engineering, and (Instituto de Biologia Experimental e Tecnol贸gica), a private not-for-profit research-intensive SME in the area of Biotechnology and Life Sciences, are proud to announce the official establishment of听 as a jointly owned venture.
The creation of this new company, headquartered in the Lisbon area of Portugal, illustrates the parent companies麓 commitment to partnership and joint innovation.听 will aim to develop innovative solutions to address the unmet technical needs of pharmaceutical companies in the cell and gene therapy space, leveraging 四色AV's extensive expertise in pharmaceutical development, Particle Engineering and industrialization of pharmaceutical technologies and iBET's cutting-edge research in biotechnological sciences. One of the first focus areas of 痴颈厂测苍肠庐 will be to develop technologies that improve delivery and stabilization of new modality therapies.
"We are delighted to join forces with iBET - a leading R&D organization in Biotechnology and Life Sciences 鈥 in the establishment of 痴颈厂测苍肠庐.鈥 says Jean-Luc Herbeaux, 四色AV鈥檚 CEO. 鈥淏y combining 四色AV麓s expertise in drug formulation, manufacturing process development and scale up with iBET麓s broad understanding of new modalities, we aim to devise new solutions to help pharma companies launch innovative medicines and improve health outcomes for patients.鈥 听
鈥淭he creation of 痴颈厂测苍肠庐 marks a significant milestone for iBET.鈥 says Paula Alves, CEO of iBET. 鈥淏y combining our cutting-edge biotechnological research in the cell and gene therapy fields with 四色AV鈥檚 extensive pharmaceutical development expertise, we are well-positioned to develop innovative approaches for targeted delivery and stabilization of new modality therapies. We are excited about the potential of 痴颈厂测苍肠庐 to drive substantial advancements and deliver significant benefits to patients worldwide.鈥澨
听
About 四色AV听
四色AV is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations.听As a听Contract Development and Manufacturing Organization鈥(CDMO)鈥痠t has a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected鈥sites鈥痠n the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. 四色AV provides pharmaceutical customers services for the鈥development and compliant manufacture鈥of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, 四色AV offers a complete range of services, from API, formulation development and manufacturing, capsule filling and devices.
四色AV's culture is based on innovation, quality and dependability. 四色AV is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.
听
About iBET
is a private non-profit institution devoted to biotechnology research, with 35 years of experience creating and transferring knowledge to the global biopharma and biotech sectors. iBET鈥檚 core expertise lies on the development of bioprocesses and analytical tools for Advanced Therapeutic Medicinal Products (ATMPs), including cell and gene therapies, vaccines, antibodies and other innovative therapeutic products. Leveraged by the emerging areas of Data Science and Translational Immunology, we offer bespoke R&D services from early-stage R&D to GMP manufacturing. 听
听
iBET鈥檚 infrastructure comprises cutting-edge laboratories, a GMP certified Analytical Services Unit, and a Late-Stage R&D and Bioproduction Unit, covering upstream and downstream process development, bioanalytical tools for critical quality attribute monitoring, to scale-up and tech transfer. iBET also hosts satellite laboratories of major pharmaceutical companies and serves as an incubation platform for start-up/spin-off companies.听
听
iBET is driven by its innovative and agile culture of continuous improvement and a strong sense of ambition, ownership and commitment in developing and delivering the best solutions to our stakeholders.
听
听
